Staar Surgical (STAA) Non-Current Assets (2010 - 2026)
Staar Surgical's (STAA) quarterly Non-Current Assets came in at $138.7 million in Q2 2026, up 6.0% YoY from $130.9 million in Q2 2025, and down 1.01% on a QoQ basis from $140.1 million in Q1 2026.
Staar Surgical (STAA) Non-Current Assets (2010 - 2026) Analysis & Trends
Staar Surgical (STAA) has 17 years of Non-Current Assets data on file, last reported at $138.7 million in Q2 2026.
- Quarterly Non-Current Assets rose 6.0% year-over-year to $138.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $559.0 million (up 1476.59% YoY) and the FY2026 annual result came in at $140.1 million, up 138.41% from the prior year.
- Non-Current Assets fell to $138.7 million in Q2 2026, from $140.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $145.0 million in Q2 2025 to a low of -$364.8 million in Q4 2024.
- A 5-year average of $38.0 million and a median of $124.5 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets retreated 16.78% — and 2026, when it jumped 138.41%.
- Tracing STAA's Non-Current Assets over 5 years: stood at -$310.4 million in 2022, then dropped by 16.78% to -$362.5 million in 2023, then slipped by 0.64% to -$364.8 million in 2024, then surged by 137.05% to $135.2 million in 2025, then rose by 2.64% to $138.7 million in 2026.
- The last three Non-Current Assets figures came in at $138.7 million (Q2 2026), $140.1 million (Q1 2026), and $135.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Staar Surgical | 1.16 Bn | 978.41 Mn | 69.73 Mn | 132.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 132.85 Mn |
| Apr 3, 2026 | 138.72 Mn |
| Jan 2, 2026 | 140.13 Mn |
| Sep 26, 2025 | 135.15 Mn |
| Jun 27, 2025 | 144.99 Mn |
| Mar 28, 2025 | 130.87 Mn |
| Dec 27, 2024 | -364.82 Mn |
| Sep 27, 2024 | 140.48 Mn |
| Jun 28, 2024 | 128.93 Mn |
| Mar 29, 2024 | 126.82 Mn |
| Dec 29, 2023 | -362.50 Mn |
| Sep 29, 2023 | 124.45 Mn |
| Jun 30, 2023 | 112.65 Mn |
| Mar 31, 2023 | 106.03 Mn |
| Dec 30, 2022 | -310.41 Mn |
| Sep 30, 2022 | 97.77 Mn |
| Jul 1, 2022 | 79.57 Mn |
| Apr 1, 2022 | 77.28 Mn |
| Dec 31, 2021 | -270.08 Mn |
| Oct 1, 2021 | 60.66 Mn |